These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37369877)

  • 41. De novo and biallelic DEAF1 variants cause a phenotypic spectrum.
    Nabais Sá MJ; Jensik PJ; McGee SR; Parker MJ; Lahiri N; McNeil EP; Kroes HY; Hagerman RJ; Harrison RE; Montgomery T; Splitt M; Palmer EE; Sachdev RK; Mefford HC; Scott AA; Martinez-Agosto JA; Lorenz R; Orenstein N; Berg JN; Amiel J; Heron D; Keren B; Cobben JM; Menke LA; Marco EJ; Graham JM; Pierson TM; Karimiani EG; Maroofian R; Manzini MC; Cauley ES; Colombo R; Odent S; Dubourg C; Phornphutkul C; de Brouwer APM; de Vries BBA; Vulto-vanSilfhout AT
    Genet Med; 2019 Sep; 21(9):2059-2069. PubMed ID: 30923367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CTNNB1 (β-CATENIN) VITREORETINOPATHY: IMAGING CHARACTERISTICS AND SURGICAL MANAGEMENT.
    Tipsuriyaporn B; Ammar MJ; Yonekawa Y
    Retin Cases Brief Rep; 2022 May; 16(3):259-262. PubMed ID: 32150115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expanding the phenotype of intellectual disability caused by HIVEP2 variants.
    Goldsmith H; Wells A; Sá MJN; Williams M; Heussler H; Buckman M; Pfundt R; de Vries BBA; Goel H
    Am J Med Genet A; 2019 Sep; 179(9):1872-1877. PubMed ID: 31207095
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genotype and Phenotype Correlations for TBL1XR1 in Neurodevelopmental Disorders.
    Quan Y; Zhang Q; Chen M; Wu H; Ou J; Shen Y; Li K; Xun G; Zhao J; Hu Z; Xia K; Guo H
    J Mol Neurosci; 2020 Dec; 70(12):2085-2092. PubMed ID: 32524419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expansion of Clinical and Genetic Spectrum of
    Dai Y; Yang Z; Guo J; Li H; Gong J; Xie Y; Xiao B; Wang H; Long L
    Front Mol Neurosci; 2022; 15():793001. PubMed ID: 35392274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation.
    Pinto AM; Bianciardi L; Mencarelli MA; Imperatore V; Di Marco C; Furini S; Suppiej A; Salviati L; Tenconi R; Ariani F; Mari F; Renieri A
    Brain Dev; 2016 Jun; 38(6):590-6. PubMed ID: 26754451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Whole-Exome Sequencing Identified a Novel DYRK1A Variant in a Patient With Intellectual Developmental Disorder, Autosomal Dominant 7.
    Obara K; Abe E; Toyoshima I
    Cureus; 2023 Jan; 15(1):e33379. PubMed ID: 36628390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Congenital heart defects associated with pathogenic variants in WAC gene: Expanding the phenotypic and genotypic spectrum of DeSanto-Shinawi syndrome.
    Quental R; Gonçalves D; Rodrigues E; Serrano Gonçalves E; Oliveira J; Parente Freixo J; Leão M
    Am J Med Genet A; 2022 Apr; 188(4):1311-1316. PubMed ID: 34997803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
    Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
    Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotype variability and allelic heterogeneity in KMT2B-Associated disease.
    Kawarai T; Miyamoto R; Nakagawa E; Koichihara R; Sakamoto T; Mure H; Morigaki R; Koizumi H; Oki R; Montecchiani C; Caltagirone C; Orlacchio A; Hattori A; Mashimo H; Izumi Y; Mezaki T; Kumada S; Taniguchi M; Yokochi F; Saitoh S; Goto S; Kaji R
    Parkinsonism Relat Disord; 2018 Jul; 52():55-61. PubMed ID: 29653907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Case report: Two cases of Poirier-Bienvenu neurodevelopmental syndrome and review of literature.
    Chen X; Han Y; Li X; Huang S; Yuan H; Qin Y
    Front Pediatr; 2023; 11():967701. PubMed ID: 37020656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phenotypic overlap between familial exudative vitreoretinopathy and microcephaly, lymphedema, and chorioretinal dysplasia caused by KIF11 mutations.
    Robitaille JM; Gillett RM; LeBlanc MA; Gaston D; Nightingale M; Mackley MP; Parkash S; Hathaway J; Thomas A; Ells A; Traboulsi EI; Héon E; Roy M; Shalev S; Fernandez CV; MacGillivray C; Wallace K; Fahiminiya S; Majewski J; McMaster CR; Bedard K
    JAMA Ophthalmol; 2014 Dec; 132(12):1393-9. PubMed ID: 25124931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PPP2R5D-Related Intellectual Disability and Neurodevelopmental Delay: A Review of the Current Understanding of the Genetics and Biochemical Basis of the Disorder.
    Biswas D; Cary W; Nolta JA
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32074998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Two Novel Mutations of
    Kim SJ; Yang A; Park JS; Kwon DG; Lee JS; Kwon YS; Lee JE
    Front Genet; 2020; 11():579805. PubMed ID: 33262785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heterozygous CTNNB1 and TBX4 variants in a patient with abnormal lung growth, pulmonary hypertension, microcephaly, and spasticity.
    Karolak JA; Szafranski P; Kilner D; Patel C; Scurry B; Kinning E; Chandler K; Jhangiani SN; Coban Akdemir ZH; Lupski JR; Popek E; Stankiewicz P
    Clin Genet; 2019 Oct; 96(4):366-370. PubMed ID: 31309540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel homozygous AP3B2 mutations in four individuals with developmental and epileptic encephalopathy: A rare clinical entity.
    Dilber C; Yücel G; Şahin Y
    Clin Neurol Neurosurg; 2022 Dec; 223():107509. PubMed ID: 36356440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and genetic analysis of six Chinese children with Poirier-Bienvenu neurodevelopmental syndrome caused by CSNK2B mutation.
    Yang S; Wu L; Liao H; Lu X; Zhang X; Kuang X; Yang L
    Neurogenetics; 2021 Oct; 22(4):323-332. PubMed ID: 34370157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A de novo PAK1 likely pathogenic variant and a de novo terminal 1q microdeletion in a Chinese girl with global developmental delay, severe intellectual disability, and seizures.
    Zhuang J; Xie M; Yao J; Fu W; Zeng S; Jiang Y; Wang Y; Xie Y; Wang G; Chen C
    BMC Med Genomics; 2023 Jan; 16(1):3. PubMed ID: 36624491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. De novo FBXO11 mutations are associated with intellectual disability and behavioural anomalies.
    Fritzen D; Kuechler A; Grimmel M; Becker J; Peters S; Sturm M; Hundertmark H; Schmidt A; Kreiß M; Strom TM; Wieczorek D; Haack TB; Beck-Wödl S; Cremer K; Engels H
    Hum Genet; 2018 May; 137(5):401-411. PubMed ID: 29796876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.
    Bonnet S; Gaujoux S; Launay P; Baudry C; Chokri I; Ragazzon B; Libé R; René-Corail F; Audebourg A; Vacher-Lavenu MC; Groussin L; Bertagna X; Dousset B; Bertherat J; Tissier F
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E419-26. PubMed ID: 21084400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.